Overall, these reports along with additional studies have described the importance and therapeutic benefit of VEGF/VEGFR-2 blockers and VEGF antagonists by ameliorating the symptoms of RA and OA [30,31,32,33,34]. The gene discussed is VEGFA; the disease is rheumatoid arthritis.